The store will not work correctly when cookies are disabled.
Pyridin-3-yl N-[5-(indol-1-yl)pentyl]carbamate
ID: ALA3585527
PubChem CID: 101885733
Max Phase: Preclinical
Molecular Formula: C19H21N3O2
Molecular Weight: 323.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCCCCCn1ccc2ccccc21)Oc1cccnc1
Standard InChI: InChI=1S/C19H21N3O2/c23-19(24-17-8-6-11-20-15-17)21-12-4-1-5-13-22-14-10-16-7-2-3-9-18(16)22/h2-3,6-11,14-15H,1,4-5,12-13H2,(H,21,23)
Standard InChI Key: BLCRQYTUEHBHFZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
5.5870 4.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0553 6.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5241 6.4042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9923 7.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4611 8.1385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1918 8.7241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9293 9.5644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3969 9.8748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8619 11.3009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8594 12.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3919 12.1064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9268 10.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1182 4.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
4 6 2 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
14 15 1 0
15 19 1 0
18 16 1 0
16 14 2 0
15 17 1 0
17 13 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
13 24 1 0
24 1 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.40 | Molecular Weight (Monoisotopic): 323.1634 | AlogP: 4.00 | #Rotatable Bonds: 7 |
Polar Surface Area: 56.15 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.82 | CX LogP: 3.40 | CX LogD: 3.40 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.67 | Np Likeness Score: -1.50 |
References
1. Terwege T, Dahlhaus H, Hanekamp W, Lehr M. (2014) -Heteroarylalkylcarbamates as inhibitors of fatty acid amide hydrolase (FAAH), 5 (7): [10.1039/C4MD00181H] |